Coover H Jr, Joyner FB, Shearer NH Jr, Wicker TH Jr. Chemistry and performance of cyanoacrylate adhesives. SPE Tech. Papers 5, 92 (1959).
Ellis RA, Levin AM. Experimental sutureless ocular surgery. Am. J. Ophthalmol. 55, 733 (1963).
Applebaum JS, Zalut T, Applebaum D. The use of tissue adhesion for traumatic laceration repair in the emergency department. Ann. Emerg. Med. 22, 1190—1192 (1993).
Pineros-Fernandez A, Rodeheaver PF, Rodeheaver GT. Octyl-2-cyanoacrylate for repair of peripheral nerve. Ann. Plast. Surg. 55, 185—195 (2005).
Kilpikari J, Lapinsuo M, Tormala P, Patiala H, Rokkanen P. Bonding strength of alkyl-2-cyanoacrylates to bone in vitro. J. Biomed. Mater. Res. 20, 1095—1102 (1986).
Vote BJT, Fraco EMJ. Cyanoacrylate glue for corneal perforations: a description of a surgical technique and a review of the literature. Clin. Exp. Opthal. 28, 437—442 (2000).
Leggat PA, Smith DR, Kedjarune U. Surgical applications of cyanoacrylate adhesives: a review of toxicity. ANZ J. Surg. 77, 209—213 (2007).
Refojo MF, Dohlman CH, Ahmad B, Caroll JM, Allen JC. Evaluation of adhesives for corneal surgery. Arch. Ophthalmol. 80, 645—656 (1968).
Refojo MF, Dohlman CH. The tensile strength of adhesive joints between eye tissues and alloplastic materials. Am. J. Ophthalmol. 68, 248—255 (1960).
Shigemitsu T, Majima Y. The utilization of biological adhesive for wound treatment: comparison of suture, self-sealing sutureless and cyanoacrylate closure in the tensile strength test. Int. Ophthalmol. 20, 323—328 (1997).
Ricci B, Ricci F, Bianchi PE. Octyl 2-cyanoacrylate in sutureless surgery of extraocular muscles: an experimental study in the rabbit model. Graefe's Arc. Clin. Exp. Ophthalmol. 238, 454—458 (2000).
Eiferman RA, Snyder JW. Antibacterial effect of cyanoacrylate glue. Arch. Ophthalmol. 101, 958—960 (1983).
de Almeida Manzano RP, Naufal FC, Hida RY et al. Antibacterial analysis in vitro of ethyl-cyanoacrylate against ocular pathogens. Cornea 25, 350—351 (2006).
Wei-Lin C, Chung-Tien L, Chia-Yun H, I-Hua T, Willie YW, Fung-Rong H. Comparison of the bacteriostatic effects, corneal cytotoxicity, and the ability to seal corneal incisions among three different tissue adhesives. Cornea 26, 1228—1234 (2007).
Romero IL, Malta JB, Silva CB, Mimica LM, Soong KH, Hida RY. Antibacterial properties of cyanoacrylate tissue adhesive: does the polymerization reaction play a role? Indian J. Ophthalmol. 57(5), 341—344 (2009).
Prause JU, Jensen OA. Studies on human corneal ulcers treated with histoacrylic glue. Morphological studies of a successful and unsuccessful membrane. Acta Ophthalmol. (Copenh.) 60, 547—556 (1982).
Fogle JA, Kenyon KR, Foster CS. Tissue adhesive arrests stromal melting in the human cornea. Am. J. Ophthalmol. 89, 795 (1980).
Webster RG Jr, Slansky HH, Refojo MF et al. The use of adhesive for the closure of corneal perforations. Report of two cases. Arch. Ophthalmol. 80, 705—709 (1968).
Weiss JL, Williams P, Lindstrom RL, Doughman DJ. The use of tissue adhesive in corneal perforations. Ophthalmology 90(6), 610—615 (1983).
Sharma A, Kaur R, Kumar S et al. Fibrin glue versus N-butyl-2-cyanoacrylate in corneal perforations. Ophthalmology 110(2), 291—298 (2003).
Singh R, Umapathy T, Abedin A, Eatamadi H, Maharajan S, Dua HS. Choroidal detachment in perforated corneal ulcers: frequency and management. Br. J. Ophthalmol. 90, 1111—1114 (2006).
Alio JL, Mulet ME, Garcia JC. Use of cyanoacrylate tissue adhesive in small-incision cataract surgery. Ophthalmic. Surg. Lasers 27(4), 270—274 (1996).
Hermel B. Studies on the use of tissue adhesives in cataract microsurgery. Polim. Med. 10(1), 3—18 (1980).
Ritterband CD, Meskin WS, Shapiro ED, Kusmierczyk J, Seedor A, Koplin SR. Laboratory model of tissue adhesive (2-octyl cyanoacrylate) in sealing clear corneal cataract wounds. Am. J. Ophthalmol. 140(6), 1039—1043 (2005).
Meskin WS, Ritterband CD, Shapiro ED et al. Bandage (2-octyl-cyanoacrylate) as a temporary wound barrier in clear corneal cataract surgery. Ophthalmology 112(11), 2015—2021 (2005).
Zalta HA, Weider HR. Closure of leaking filtering blebs with cyanoacrylate tissue adhesive. Br. J. Ophthalmol. 75, 170—173 (1991).
Weber PA, Baker ND. The use of cyanoacrylate adhesive with a collagen shield in leaking filtering blebs. Ophthal. Surg. 20(4), 284—285 (1998).
Grady FJ, Forbes M. Tissue adhesive for repair of conjunctival buttonhole in glaucoma surgery. Am. J. Ophthalmol. 68, 656—658 (1969).
Awan KJ, Spaeth PG. Use of isobutyl 2-cyanoacrylate tissue adhesive in the repair of conjunctival fistula in filtering procedures of glaucoma. Ann. Ophthalmol. 6, 851—853 (1974).
Hartnett ME, Hirose T. Cyanoacrylate glue in the repair of retinal detachment associated with posterior retinal breaks in infants and children. Retina 18(2), 125—129 (1998).
Sheta SM, Hida T, McCuen BW. Experimental transvitreal cyanoacrylate retinopexy through silicone oil. Am. J. Ophthalmol. 102(6), 717—722 (1986).
Sternberg P, Tiedeman J, Prensky JG. Sutureless scleral buckle for retinal detachment with thick sclera. Retina 8(4), 247—249 (1988).
Ricci B, Ricci F. Octyl-2-cyanoacrylate tissue adhesive in experimental scleral buckling. Acta Ophthalmol. Scand. 78, 506—508 (2001).
Gilbert CE, Grierson I, McLeod D. Retinal patching: a new approach to the management of selected retinal breaks. Eye (Lond.) 3(1), 19—26 (1989).
Sheta SM, Hida T, McCuen BW. Cyanoacrylate tissue adhesive in the management of recurrent retinal detachment caused by macular hole. Am. J. Ophthalmol. 109(1), 28—32 (1990).
Lim LT, Bhatt PR, Ramaesh K. Harvesting keratolimbal allografts from corneoscleral buttons: a novel application of cyanoacrylate adhesive. Br. J. Ophthalmol. 92, 1550—1551 (2008).
Gupta KB, Edward D, Duffy TM. 2-Octyl cyanoacrylate tissue adhesive and muscle attachment to porous anophthalmic orbital implants. Ophthal. Plast. Reconstr. Surg. 17, 264—269 (2001).
Gallwmore RP, Green J, Shorr N, Goldberg RA. Use of isobutyl cyanoacrylate tissue adhesive to stabilize mucous membrane grafts in total socket reconstruction. Ophthal. Plast. Reconstr. Surg. 15(3), 210—212 (1999).
Shepler, TR, Stuart R. Use of isobutyl cyanoacrylate tissue adhesive to stabilize external eyelid weights in temporary treatment of facial palsies. Ophthal. Plast. Reconstr. Surg. 17(3), 169—173 (2001).
Bhatia SS. Ocular surface sealants and adhesives. Ocul. Surf. 4(3), 146—154 (2006).
Vanathi M, Sharma N, Titiyal JS. Tectonic grafts for corneal thinning and perforations. Cornea 21, 792—797 (2002).
Foster CS. Tissue adhesives. In: Smolin and Toft^ys The Cornea: Scientific Foundations and Clinical Practice (4th Edition). Lippincott Williams and Wilkins, PA, USA, 437—442 (2005).
Wessels IF, McNeill JI. Applicator for cyanoacrylate tissue adhesive. Ophthalmic Surg. 20, 211—214 (1989).
Boruchoff SA, Donshik PC. Medical and surgical management of corneal thinnings and perforations. Int. Ophthalmol. Clin. 15, 111—123 (1975).
Jackson MR, MacPhee MJ, Drohan WN, Alving BM. Fibrin sealant: current and potential clinical applications. Blood Coagul. Fibrinolysis 7, 737—746 (1996).
Chung SI. Comparative studies on tissue transglutaminase and Factor XIII. Ann. NY Acad. Sci. 202, 240—255 (1972).
Iwanaga S, Suzuki K, Hashimoto S. Bovine plasma cold-insoluble globulin: gross structure and function. Ann. NY Acad. Sci. 31256—31273 (1978).
Sakata Y, Aoki N. Significance of cross-linking of a2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. J. Clin. Invest. 69(3), 536—542 (1982).
Spotnitz WD. Fibrin sealant: past, present, and future: a brief review. World J. Surg. 34(4), 632—634 (2010).
Young J, Medawar P. Fibrin suture of peripheral nerves. Lancet 1(7), 77 (1943).
Cronkite EP, Lozner EL, Deaver J. Use of thrombin and fibrinogen in skin grafting. JAMA 124, 976—978 (1944).
Dresdale A, Rose EA, Jeevanandam V. Preparation of fibrin glue from single-donor fresh-frozen plasma. Surgery 97, 750—755 (1985)
Tredree R, Beierlein W, Debrix I et al. Evaluating the differences between fibrin sealants: recommendations from an international advisory panel of hospital pharmacists. Eur. J. Hosp. Pharm. Sci. 12(1), 3—9 (2006).
• Excellent comparison of commonly used fibrin glues.
Martinowtiz U, Bal F. Improved tissue glue prepared by using cyroprecitpitate. EP (application) Assigned to Octapharma AG Patent 534,178 (1993).
Bar L, Malka O, Naboichenko E, Nur I, The binding of fibrin sealant to collagen is influenced by the method of purification and the cross-linked fibrinogen—fibronectin (heteronectin) content of the 'fibrinogen' component. Blood Coagul. Fibrinolysis 16(2), 111—117 (2005) .
•• Good investigation into the effect of different fibrin glue purification methods on bonding ability to collagen.
Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N. Engl. J. Med. 354(4), 353—365 (2006) .
Nhunsberger, Microsoft Word — 5332— 0002SCD_Vitagel Hemostat IFU — US_ Rev.01_SCD.doc. 21 June 2007 (2010).
Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann. Surg. 233(1), 88—96 (2001).
Rock G, Berger R, Lange J, Tokessy M, Palmer,DS, Giulivi A. A novel, automated method of temperature cycling to produce cryoprecipitate. Transfusion 41(2), 232—235 (2001).
Tidrick RT, Warner ED. Fibrin fixation of skin transplants. Surgery 15 (1), 90—95 (1944).
Katzin HM. Aqueous fibrin fixation of corneal transplants in the rabbit. Arch. Ophthalmol. 35, 415—420 (1945).
Prabhasawat P, Barton, K, Burkett G, Tseng SCG. Comparison of conjunctival autografts amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 104(6), 974—985 (1997).
Koranyi G, Seregard S, Kopp ED. The cut-and-paste method for primary pterygium surgery: long-term follow-up. Acta Ophthalmol. Scand. 83(3), 298—301 (2005).
Sridhar MS, Bansal AK, Rao GN. Surgically induced necrotizing scleritis after pterygium excision and conjunctival autograft. Cornea 21, 305—307 (2002).
Suzuki T, Sano Y, Kinoshita S. Conjunctival inflammation induces Langerhans' cell migration into the cornea. Curr. Eye Res. 21(1), 550—553 (2000).
Koranyi G, Seregard S, Kopp ED. Cut and paste: a no suture, small incision approach to pterygium surgery. Br. J. Ophthalmol. 88(7), 911—914 (2004).
Hall RC, Logan AJ, Wells AP. Comparison of fibrin glue with sutures for pterygium excision surgery with conjunctival autografts. Clin. Exp. Ophthalmol. 37(6), 584—589 (2009).
Karalezli A, Kucukerdonmez C, Akova YA, Altan-Yaycioglu R, Borazan M. Fibrin glue versus sutures for conjunctival autografting in pterygium surgery: a prospective comparative study. Br. J. Ophthalmol. 92(9), 1206—1210 (2008).
Ratnalingam V, KeatEu AL, Ng GL, Taharin R, John E. Fibrin adhesive is better than sutures in pterygium surgery. Cornea 29(5), 485—489 (2010).
Ozdamar Y, Mutevelli S, Han U et al. A comparative study of tissue glue and vicryl suture for closing limbal— conjunctival autografts and histologic evaluation after pterygium excision. Cornea 27(5), 552—558 (2008).
Uy HS, Reyes JMG, Flores JDG et al. Comparison of fibrin glue and sutures for attaching conjunctival autografts after pterygium excision.Ophthalmology 112(4), 667—671 (2005).
Jiang J, Yang Y, Zhang M, Fu X, Bao X, Yao K. Comparison of fibrin sealant and sutures for conjunctival autograft fixation in pterygium surgery: one-year follow-up. Ophthalmologica 222(2), 105—111 (2008).
Pan HW, Zhong JX, Jing CX. Comparison of fibrin glue versus suture for conjunctival autografting in pterygium surgery: a meta-analysis. Ophthalmology 118(6), 1049—1054 (2011).
• Pooled analysis of seven studies with interesting new significant findings, which highlights the need for large population and long-term cohort studies.
Solomon A, Pires RTF, Tseng SCG. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology 108(3), 449—460 (2001).
Jain AK, Bansal R, Sukhija J. Human amniotic membrane transplantation with fibrin glue in management of primary pterygia: a new tuck-in technique. Cornea 27(1), 94—99 (2008).
Kheirkhah A, Casas V, Sheha H, Raju VK, Tseng SC. Role of conjunctival inflammation in surgical outcome after amniotic membrane transplantation with or without fibrin glue for pterygium. Cornea 27(1), 56—63 (2008).
Zauberman H, Hemo I. Use of fibrin glue in ocular surgery. Ophthalmic Surg. 19(2), 132—133 (1988).
Biedner B, Rosenthal G. Conjunctival closure in strabismus surgery: vicryl versus fibrin glue. Opthalmic Surg. 27(11), 967 (1996).
Dadeya S, Kamlesh MS. Strabismus surgery: fibrin glue versus vicryl for conjuctival closure. Acta Ophthalmol. Scand. 79(5), 515—517 (2001).
Mohan K, KaurMalhi R, Sharma A, Kumar S. Fibrin glue for conjunctival closure in strabismus surgery. J. Pediat. Opthalmol. Strabismus 40(3), 158—160 (2003).
Tonelli E Jr, De Almeida HC, Bambirra EA. Tissue adhesives for a sutureless fadenoperation: an experimental study in a rabbit model. Invest. Ophthalmol. Visual Sci. 45(12), 4340—4345 (2004).
Krzizok T. Fibrin glue for closing conjunctival wounds in ophthalmic surgery. Ophthalmologe 101(10), 1006—1010 (2004).
Lagoutte FM, Gauthier L, Comte PRM. A fibrin sealant for perforated and preperforated corneal ulcers. Br. J. Ophthalmol. 73(9), 757—761 (1989).
Duchesne B, Tahi H, Galand A. Use of human fibrin glue and amniotic membrane transplant in corneal perforation. Cornea 20(2), 230—232 (2001).
Gupta N, Sachdev R, Tandon R. Sutureless patch graft for sterile corneal melts. Cornea 29(8), 921—923 (2010).
Chen HC, Tan HY, Hsiao CH, Huang SCM, Lin KK, Ma DHK. Amniotic membrane transplantation for persistent corneal ulcers and perforations in acute fungal keratitis. Cornea 25(5), 564—572 (2006) .
Kim HK, Park HS. Fibrin glue-assisted augmented amniotic membrane transplantation for the treatment of large noninfectious corneal perforations. Cornea 28(2), 170—176 (2009).
Kheirkhah A, Casas V, Raju VK, Tseng SCG. Sutureless amniotic membrane transplantation for partial limbal stem cell deficiency. Am. J. Ophthalmol. 145(5), 787—794 (2008).
Kheirkhah A, Casas V, Blanco G. Amniotic membrane transplantation with fibrin glue for conjunctivochalasis. Am. J. Ophthalmol. 144(2), 311—313 (2007).
Hick S, Demers PE, Brunette I, La C, Mabon M, Duchesne B. Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea 24(4), 369—377 (2005).
Sekiyama E, Nakamura T, Kurihara E et al. Novel sutureless transplantation of bioadhesive-coated, freeze-dried amniotic membrane for ocular surface reconstruction. Invest. Ophthalmol. Visual Sci. 48(4), 1528—1534 (2007).
Rostron CK, Brittain GP, Morton DB, Rees JE. Experimental epikeratophakia with biological adhesive. Arch. Ophthalmol. 106(8), 1103—1106 (1988).
Kim MS, Kim JH. Effects of tissue adhesive (Tisseel) on corneal wound healing in lamellar keratoplasty in rabbits. Korean J. Ophthalmol. 3(1), 14—21 (1989).
Rosenthal AR, Harbury C, Egbert PR, Rubenstein E. Use of a platelet fibrinogen thrombin mixture as a corneal adhesive: experiments with sutureless lamellar keratoplasty in the rabbit. Invest. Ophthalmol. 14(11), 872—875 (1975).
Hashemi H, Dadgostar A. Automated lamellar therapeutic keratoplasty with fibrin adhesive in the treatment of anterior corneal opacities. Cornea 30(6), 655—659 (2011).
Duarte MCB, Kim T. Sutureless lamellar keratoplasty: a modified approach for fibrin glue application. Cornea 26(9), 1127—1128 (2007) .
Chen W, Qu J, Lu F, Zhu RY. Sutureless lamellar keratoplasty by microkeratome combined with fibrin tissue adhesive in rabbits. Chinese J. Ophthalmol. 40(5), 331—336 (2004).
Narendran N, Mohamed S, Shah S. No sutures corneal grafting — a novel use of overlay sutures and fibrin glue in deep anterior lamellar keratoplasty. Cont. Lens Ant. Eye 30(3), 207—209 (2007).
Oberg TJ, Friday JW, Ursea R, Snyder RW. Is Tisseel a viable option in posterior lamellar keratoplasty? Cornea 28 (6), 681—687 (2009).
Por YM, Tan YL, Mehta JS, Tan DTH. Intracameral fibrin tissue sealant as an adjunct in tectonic lamellar keratoplasty for large corneal perforations. Cornea 28(4), 451—455 (2009).
Bahar I, Kaiserman I, Slomovic A, McAllum P, Rootman D. Fibrin glue for opposing wound edges in 'top hat' penetrating keratoplasty: a laboratory study. Cornea 26(10), 1235—1238 (2007).
Sonmez B, Beden A. Fibrin glue-assisted sutureless limbal stem cell transplantation surgery for the treatment of severe ocular chemical injury. Cornea 30(3), 296—300 (2010).
Nassiri N, Pandya HK, Djalilian AR. Limbal allograft transplantation using fibrin glue. Arch. Ophthalmol. 129(2), 218—222 (2011).
Zakaria N, Koppen C, Van Tendeloo V, Berneman Z, Hopkinson A, Tassignon MJ. Standardized limbal epithelial stem cell graft generation and transplantation. Tissue Eng. Part C Methods 16(5), 921—927 (2010).
Pfister R, Sommers CI. Fibrin sealant in corneal stem cell transplantation. Cornea 24(5), 593—598 (2005).
Higa K, Shimazaki J. Recent advances in cultivated epithelial transplantation. Cornea 27(Suppl. 1), S41—S47 (2008).
Narvaez J, Chakrabarty A, Chang K. Treatment of epithelial ingrowth after L ASIK enhancement with a combined technique of mechanical debridement, flap suturing, and fibrin glue application. Cornea 25(9), 1115—1117 (2006).
Elderkin SJ, Epstein RJ, Seldomridge DL. Successful treatment of recurrent epithelial ingrowth associated with interface fluid syndrome, flap necrosis, and epithelial defects following LASIK. J. Refract. Surg. 27(1), 70—73 (2011).
Yeh DL, Bushley DM, Kim T. Treatment of traumatic LASIK flap dislocation and epithelial ingrowth with fibrin glue. Am. J. Ophthalmol. 141(5), 960—962 (2006).
Szurman P, Warga M, Grisanti S et al. Sutureless amniotic membrane fixation using fibrin glue for ocular surface reconstruction in a rabbit model. Cornea 25(4), 460—466 (2006).
Azar G, Doan S, Cochereau I, Gabison EE. Management of post-LASIK recurrent epithelial ingrowth with flap melting using annular amniotic membrane graft. J. Cataract Refract. Surg. 36(12), 2207—2208 (2010).
Bonatti JA, Bechara SJ, Dall'Col MW, Cresta FB, Carricondo PC, Kara-Jose N. A fibrin-related line of research and theoretical possibilities for the use of fibrin glue as a temporary basal membrane in non-perforated corneal ulcers and in photorefractive keratectomy (PRK)-operated corneas. Arq. Bras. Oftalmol. 70(5), 884—889 (2007).
O'Sullivan F, Dalton R, Rostron CK. Fibrin glue: an alternative method of wound closure in glaucoma surgery. J. Glaucoma 5(6), 367—370 (1996).
Gammon, RR, Prum BE Jr, Avery N, Mintz PD. Rapid preparation of small-volume autologous fibrinogen concentrate and its same day use in bleb leaks after glaucoma filtration surgery. Ophthal. Surg. Lasers 29(12), 1010—1012 (1998).
Asrani SG, Wilensky JT. Management of bleb leaks after glaucoma filtering surgery: use of autologous fibrin tissue glue as an alternative. Ophthalmology 103 (2), 294—298 (1996).
Grewing R, Mester U. Fibrin sealant in the management of complicated hypotony after trabeculectomy. Ophthal. Surg. Lasers 28(2), 124—127 (1997).
Wright MM, Brown EA, Maxwell K, Cameron JD, Walsh AW. Laser-cured fibrinogen glue to repair bleb leaks in rabbits. Arch. Ophthalmol. 116(2), 199—202 (1998).
Seligsohn A, Moster MR, Steinmann W, Fontanarosa J. Use of tisseel fibrin sealant to manage bleb leaks and hypotony: case series. J. Glaucoma 13(3), 227 (2004).
Lee GA, Holcombe DJ. Surgical revision of dysfunctional filtration blebs with bleb preservation, sliding conjunctival flap and fibrin glue. Eye 24(6), 947—953 (2009).
Bahar I, Weinberger D, Lusky M, Avisar R, Robinson A, Gaton D. Fibrin glue as a suture substitute: histological evaluation of trabeculectomy in rabbit eyes. Curr. Eye Res. 31(1), 31—36 (2006).
Freeman PD, Kahook MY, Curtis TH. Glaucoma drainage device implantation in children using fibrin glue. J. AAPOS 14(2), 169—171 (2010).
Kahook MY, Noecker RJ. Fibrin glue-assisted glaucoma drainage device surgery. Br. J. Ophthalmol. 90(12), 1486—1489 (2006).
Valimakii J. Fibrin glue for preventing immediate postoperative hypotony following glaucoma drainage implant surgery. Acta Ophthalmol. Scand. 84(3), 372—374 (2006).
Hovanesian JA, Karageozian VH. Watertight cataract incision closure using fibrin tissue adhesive. J. Cataract Refract. Surg. 33(8), 1461—1463 (2007).
Kim T, Kharod BV. Tissue adhesives in corneal cataract incisions. Curr. Opin. Ophthalmol. 18(1), 39—43 (2007).
Mulet Homs ME, Alio Y, Sanz JL, Gobby F. Efficacy of fibrinogen as bioadhesive in cataract surgery through scleral tunnel. J. Cataract Refract. Surg. 72(6), 427—430 (1997).
Grewing R, Mester U. Radial suture stabilized by fibrin glue to correct preoperative against — the-rule astigmatism during cataract surgery. Ophthal. Surg. 25(7), 446—448 (1994).
Henrick A, Kalpakian B, Gaster RN, Vanley C. Organic tissue glue in the closure of cataract incisions in rabbit eyes. J. Cataract Refract. Surg. 17(5), 551—555 (1991).
Henrick A, Gaster RN, Silverstone PJ. Organic tissue glue in the closure of cataract incisions. J. Cataract Refract. Surg. 13(5), 551—553 (1987).
Kumar DA, Agarwal A, Prakash G, Jacob S, Saravanan Y, Agarwal A. Glued posterior chamber IOL in eyes with deficient capsular support: a retrospective analysis of 1-year postoperative outcomes. Eye 24(7), 1143—1148 (2010).
Agarwal A, Kumar DA, Jacob S, Baid C, Agarwal A, Srinivasan S. Fibrin glue-assisted sutureless posterior chamber intraocular lens implantation in eyes with deficient posterior capsules. J. Cataract Refract. Surg. 34(9), 1433—1438 (2008).
Buschmann W. Microsurgical treatment of lens capsule perforations. Part II: clinical applications and resu lts. Ophthal. Surg. 18(3), 276—282 (1987).
Coleman DJ, Lucas BC, Fleischman JA. A biologic tissue adhesive for vitreoretinal surgery. Retina 8(4), 250—256 (1988).
Uhlig CE, Gerding H. Fibrin sealing improves stability of corneal prostheses during vitreoretinal procedures. Retina 23(2), 209—214 (2003).
Goessl A, Redl H. Optimized thrombin dilution protocol for a slowly setting fibrin sealant in surgery. Acta Chirurgica Austriaca 37(1), 43—51 (2005).
Champalakshmi R, Chaurasia SS, Angunawaela RI, Tan DT, Mehta JS. Optimization and comparison of fibrin glue spray system for ocular delivery. Presented at: Asia ARVO. Singapore, 20—22 January 2011 (Poster #728).
Wilson SM, Pell P, Donegan EA. HIV-1 transmission following the use of cryoprecipitate fibrinogen as gel/adhesive. Transfusion 31, S51 (1991).
Hino M, Ishiko O, Honda KI et al. Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br. J. Haematol. 108, 194—195 (2000).
Rubel C, Fernandez GC, Dran G, Bompadre MB, Isturiz MA, Palermo MS. Fibrinogen promotes neutrophil activation and delays apoptosis. J. Immunol. 166, 2002—2010 (2001).
Banninger H, Hardegger T, Tobler A et al. Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human Factor V. Br. J. Haematol. 855, 528—532 (1993).
Rapaport SI, Zivelin A, Minow R, Hunter CS, Donnelly K. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. Am. J. Clin. Pathol. 97, 84—91 (1992).
Carnahan MA, Grinstaff MW. Synthesis and characterization of poly(glycerol-succinic acid) dendrimers. Macromolecules 34(22), 7648—7655 (2001).
Berdahl JP, Johnson CS, Proia AD, Grinstaff MW, Kim T. Comparison of sutures and dendritic polymer adhesives for corneal laceration repair in an in vivo chicken model. Arch. Ophthalmol. 127(4), 442—447 (2009).
Johnson CS, Wathier M, Grinstaff M, Kim T. In vitro sealing of clear corneal cataract incisions with a novel biodendrimer adhesive. Arch. Ophthalmol. 127(4), 430—434 (2009).
Wathier M, Jung PJ, Carnahan MA, Kim T, Grinstaff MW. Dendritic macromers as in situ polymerizing biomaterials for securing cataract incisions. J. Am. Chem. Soc. 126(40), 12744—12745 (2004).
Kang C, Carnahan MA, Wathier M, Grinstaff MW, Kim T. Novel tissue adhesives to secure laser in situ keratomileusis flaps. J. Cataract Refract. Surg. 31(6), 1208—1212 (2005).
Wathier M, Johnson MS, Carnahan MA et al. In situ polymerized hydrogels for repairing scleral incisions used in pars planavitrectomy procedures. ChemMedChem 1(8), 821—825 (2006).
Degortcija L, Starck Johnson C, Wathier M, Kim T, Grinstaff MW. Photo cross-linkable biodendrimers as ophthalmic adhesives for central lacerations and penetrating keratoplasties. Invest. Ophthalmol. Visual Sci. 48(5), 2037—2042 (2007).
Velazquez AJ, Carnahan MA, Kristinsson J, Stinnett S, Grinstaff MW, Kim T. New dendritic adhesives for sutureless ophthalmic surgical procedures: in vitro studies of corneal laceration repair. Arch. Ophthalmol. 122(6), 867—870 (2004).
Kang PC, Jung PJ, Carnahan MA, Kim T, Grinstaff MW. Novel tissue adhesives to secure laser in situ keratomileusis flaps. J. Cataract Refract. Surg. 31(6), 1208—1212 (2005).
Araki M, Tao H, Nakajima N et al. Development of new biodegradable hydrogel glue for preventing alveolar air leakage. J. Thorac. Cardiovasc. Surg. 134(5), 1241—1248 (2007).
Nakajima N, Sugai H, Tsutsumi S, Hyon SH. Self-degradable bioadhesives. Key Eng. Mat. 342, 713—716 (2007).
Takaoka M, Nakamura T, Sugai H. Sutureless amniotic membrane transplantation for ocular surface reconstruction with a chemically defined bioadhesive. Biomaterials 29(19), 2923—2931 (2008).
Takaoka M, Nakamura T, Sugai H. Novel sutureless keratoplasty with a chemically defined bioadhesive. Invest. Ophthalmol. Visual Sci. 50(6), 2679—2685 (2009).
Kirker KR, Luo Y, Nielson JH, Shelby J, Prestwich GD. Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials 23(17), 3661—3671 (2002).
Reyes JMG, Herretes S, Pirouzmanesh A. A modified chondroitin sulfate aldehyde adhesive for sealing corneal incisions. Invest. Ophthalmol. Visual Sci. 46(4), 1247—1250 (2005).
Braunwald NS, Gay W, Tatooles CJ. Evaluation of crosslinked gelatin as a tissue adhesive and hemostatic agent: an experimental study. Surgery 59(6), 1024—1030 (1966).
Sung HW, Huang DM, Chang WH, Huan RN, Hsu JC. Evaluation of gelatin hydrogel crosslinked with various crosslinking agents as bioadhesives: in vitro study. J. Biomed. Mat. Res. 46(4), 520—530 (1999).
Ennker J, Ennker IC, Schoon D et al. The impact of gelatin-resorcinol glue on aortic tissue: a histomorphologic evaluation. J. Vasc. Surg. 20(1), 34—43 (1994).
Ennker IC, Ennker J, Schoon D, Schoon HA, Rimpler M, Hetzer R. Formaldehyde-free collagen glue in experimental lung gluing. Ann. Thorac. Surg. 57(6), 1622—1627 (1994).
Wertzel H, Wagner B, Stricker A et al. Experimental gluing of lung parenchyma in rats. Thorac. Cardiovasc. Surgeon 45 (2), 83—87 (1997).
Chao HH, Torchiana DF. BioGlue: albumin/glutaraldehyde sealant in cardiac surgery. J. Card. Surg. 18(6), 500—503 (2003).
Anghelacopoulos SE, Tagarakis GI, Pilpilidis I, Kartsounis C, Chryssafis G. Albumin—glutaraldehyde bioadhesive ('Bioglue') for prevention of postoperative complications after stapled hemorrhoidopexy: a randomized controlled trial. Wien. Klin. Wochenschr. 118(15 —16), 469—472 (2006).
Engel HM, Chechik D, Burde RM. Repair of a traumatic scleral rupture with scleral imbrication and BioGlue. Retina 27(4), 505—508 (2007).
Furst W, Banerjee A. Release of glutaraldehyde from an albumin— glutaraldehyde tissue adhesive causes significant in vitro and in vivo toxicity. Ann. Thorac. Surg. 79(5), 1522—1528 (2005).
Khadem J, Martino M, Anatelli F, Dana MR, Hamblin MR. Healing of perforating rat corneal incisions closed with photodynamic laser-activated tissue glue. Lasers Surg. Med. 35(4), 304—311 (2004).
Khadem JJ. Dana MR. Photodynamic biologic tissue glue in perforating rabbit corneal wounds. J. Clin. Laser Med. Surg. 18(3), 125—129 (2000).
Bloom JN, Duffy MT, Davis JB, McNally-Heintzelman KM. A scaffold-enhanced laser-activated surgical adhesive technique for sutureless strabismus surgery. Invest. Ophthalmol. Visual. Sci. 44 (2003) (E-Abstract 2748).
Bloom JN, Duffy MT, Davis JB, McNally-Heintzelman KM. A light-activated surgical adhesive technique for sutureless ophthalmic surgery. Arch. Ophthalmol. 121(11), 1591—1595 (2003).
Letko E, Majmudar PA, Forstot SL, Epstein RJ, Rubinfeld RS. UVA-light and riboflavin-mediated corneal collagen cross-linking. Int. Ophthalmol. Clin. 51(2), 63—76 (2011).
Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am. J. Ophthalmol. 135(5), 620—627 (2003).
Raiskup-Wolf F, Hoyer A, Spoerl E et al. Collagen crosslinking with riboflavin andultraviolet-A light in keratoconus: long-term results. J. Cataract Refract. Surg. 347, 796—801 (2008).
Kohlhaas M, Spoerl E, Speck A et al. [A new treatment of keratectasia after LASIK by using collagen with riboflavin/UVA light cross-linking.] Klin. Monbl. Augenheilkd. 222, 430—436 (2005).
Hafezi F, Kanellopoulos J, Wiltfang R et al. Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis. J. Cataract Refract. Surg. 33, 2035—2040 (2007).
Wollensak G, Sparl E, Reber F, Pillunat L, Funk R. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophthal. Res. 35(6), 324—328 (2003).
Kissner A, Spoerl E, Jung R, Spekl K, Pillunat LE, Raiskup F. Pharmacological modification of the epithelial permeability by benzalkonium chloride in UVA/riboflavin corneal collagen cross-linking. Curr. Eye Res. 35(8), 715—721 (2010).
Chan CCK, Sharma M, Wachler BSB. Effect of inferior-segment Intacs with and without C3-R on keratoconus. J. Cataract Refract. Surg. 33(1), 75—80 (2007).
Miki D, Dastgheib K, Kim T et al. A photopolymerized sealant for corneal lacerations. Cornea 21(4), 393—399 (2002).
Rossi F, Pini R, Menabuoni L et al. Experimental study on the healing process following laser welding of the cornea. J. Biomed. Optics 10(2), 1—7 (2005).
Pini R, Rossi F, Menabuoni L et al. In diode laser welding for cornea suturing: an experimental study of the repair process. Proc. SPIE Biomed. Optics Imag. 245 —252 (2004).
L'Esperance FA Jr. Argon and ruby laser photocoagulation of disciform macular disease. Trans. Am. Acad. Opthalmol. Otolaryngol. 75(3), 609—628 (1971).
Timberlake GT, Patmore A, Shallal A, Marshall J, McHugh D. Thermal and infrared-diode laser effects on indocyanine-green-treated corneal collagen. Proc. SPIE Int. Soc. Optical Eng. 1882, 244—253 (1993).
Pini R, Menabuoni L, Starnotti L. First application of laser welding in clinical transplantation of the cornea. Proc. SPIE Int. Soc. Optical Eng. 2001, 266—271 (2001).
Deckelbaum LI, Isner JM, Donaldson RF. Use of pu lsed energy delivery to minimize tissue injury resulting from carbon dioxide laser irradiation of cardiovascular tissues. J. Am. Coll. Cardiol. 7(4), 898—908 (1986).
Burstein NL, Williams JM Sr, Nowicki MJ, Johnson DE, Jeffers WQ. Corneal welding using hydrogen fluoride lasers². Arch. Ophthalmol. 110(1), 12—13 (1992).
Trabucchi G, Gobbi PG, Brancato R et al. Laser welding of corneal tissue: preliminary experiences using 810nm and 1950nm diode lasers, Proc. SPIE Int. Soc. Optical Eng. 1996, 380—387 (1996).
Matteini, P, Rossi F, Menabouni L, Pini R. Microscopic analysis of structural changes in diode-laser-welded corneal stroma. Proc. SPIE Int. Soc. Optical Eng. 6426, 14 (2007).
Menabuoni L, Pini R, Rossi F, Lenzetti I, Yoo SH, Parel JM. Laser-assisted corneal welding in cataract surgery: retrospective study. J. Cataract Refract. Surg. 33 (9), 1608—1612 (2007).
Menabuoni L, Minicione F, Minicione GP, Pini R. Laser welding to assist penetrating keratoplasty: in vivo studies. Proc. SPIE Int. Soc. Optical Eng. 3195, 25 (1998).
Kirsch AJ, Miller MI, Hensle TW. Laser tissue soldering in urinary tract reconstruction: first human experience. Urology 46(2), 261—266 (1995).
Khadem J, Truong T, Ernest JT. Photodynamic biologic tissue glue. Cornea 13(5), 406—410 (1994).
Bass LS, Treat MR. Laser tissue welding: a comprehensive review of current and future clinical applications. Lasers Surg. Med. 17(4), 315—349 (1995).
Poppas DP, Schlossberg SM, Richmond IL, Gilbert DA, Devine CJ Jr. Laser welding in urethral surgery: improved results with a protein solder. Urology 139(2), 415—417 (1988).
Noguera G, Lee WS, Castro-Combs J et al. Novel laser-activated solder for sealing corneal wounds. Invest. Ophthalmol. Visual Sci. 48(3), 1038—1042 (2007).
Gobin A, O'Neal DP, Halas NJ, West J. Nanoshells as near infrared absorbers to enhance laser tissue welding, Transactions. Presented at: 7th World Biomaterials Congress. Sydney, Australia, 17—21 May 2004.
Gobin AM, O'Neal DP, Halas NJ, Drezek RA, West JL. Laser tissue soldering with near-infrared absorbing nanoparticles. Proc. SPIE Biomed. Optics Imag. 261—266 (2005).
Ratto F, Matteini P, Rossi F et al. Photothermal effects in connective tissues mediated by laser-activated gold nanorods. Nanomedicine 5(2), 143—151 (2009).
Rossi F, Matteini P, Ratto F, Menabuoni L, Lenzetti I, Pini R. Laser welding of chitosan-GNRs films for the closure of a capsulorhexis. Proc. SPIE Biomed. Optics Imag. 7885, 78851O-78851O-4 (2011).
Hirsch LR, Stafford RJ, Bankson JA et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl Acad. Sci. USA 100(23), 13549—13554 (2003).
Schober R, Ulrich F, Sander T. Laser-induced alteration of collagen substructure allows microsurgical tissue welding. Science 232(4756), 1421—1422 (1986).
• Sheds visual illumination on the mechanism of instantaneous laser tissue welding on the microlevel.
Timberlake GT, Patmore A, Shallal A, McHugh D, Marshall J. Thermal and infrared-diode laser effects on indocyanine-green-treated corneal collagen. Proc. SPIE Int. Soc. Optical Eng. 1882, 244—253 (1993).
Allain JC, Le Lous M, Cohen-Solal L. Isometric tensions developed during the hydrothermal swelling of rat skin. Connective Tissue Res. 7(3), 127—133 (1980).
Hayashi K, Thabit IG, Bogdanske JJ, Mascio LN, Markel MD. The effect of nonablative laser energy on the ultrastructure of joint capsular collagen. Arthroscopy 12(4), 474—481 (1996).
Aeschlimann D, Thomazy V. Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connective Tissue Res. 41(1), 1—27 (2000).
Griffin M, Casadio R, Bergamini CM. Transglutaminases: nature's biological glues. Biochem. J. 368(2), 377—396 (2002).
Jürgensen K, Aeschlimann D, Cavin V, Genge M, Hunziker EB. A new biological glue for cartilage—cartilage interfaces: tissue transglutaminase. J. Bone Joint Surg. A 79(2), 185—193 (1997).
•• Seminal study providing evidence of different bonding interactions of plasma transglutaminase and tissue transglutaminase to tissue, and the first study to apply TGase-2 as a tissue adhesive.
Raghunat, M, Hopfner B, Aeschlimann D et al. Cross-linking of the dermo-epidermal junction of skin regenerating from keratinocyte autografts: anchoring fibrils are a target for tissue transglutaminase. J. Clin. Invest. 98(5), 1174—1184 (1996).
Kaartinen MT, Murshed M, Karsenty G, McKee MD. Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of matrix Gla protein-deficient mice. J. Histochem. Cytochem. 55(4), 375—386 (2007).
Samuelsson B, Stenberg P, Pandolfi M. Localization and characteristics of transglutaminase in the rabbit and human eye. Graefe's Arch. Clin. Exp. Ophthalmol. 218(5), 233—236 (1982).
Hidasi V, Adany R, Muszbek L. Localization of transglutaminase in human lenses. J. Histochem. Cytochem. 43(11), 1173—1177 (1995).
Raghunath M, Cankay R, Kubitscheck U. Transglutaminase activity in the eye: cross-linking in epithelia and connective tissue structures. Invest. Ophthalmol. Visual Sci. 40(12), 2780—2787 (1999).
Panengad P, Salazar G, Liew M et al. Biological cornea glue — in vitro evaluation. Presented at: ARVO Annual Meeting. Fort Lauderdale, FL, USA, 4—19 May 2010.

Patent
301. Schwartz O, Linnau Y, Loblich F et al. : Patent no. 4377572 (1982).

Websites
401. US FDA. Vitagel^™Surgical Hemostat — P050044. www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm078128.htm
402. US FDA. FDA's Role. www.fda.gov/cdrh/pdf/p010003b.pdf 2001

Papers of special note have been highlighted as:
• of interest
•• of considerable interest

CME

Tissue Adhesives in Ocular Surgery

Authors: Heyjin C. Park; Ravi Champakalakshmi; Pradeep P. Panengad; Michael Raghunath, MD, PhD; Jodhbir S. Mehta, FRCS (Ed)
CME Released: 11/21/2011
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 11/21/2012

Target Audience and Goal Statement

This activity is intended for ophthalmologists and other physicians who might use tissue adhesives for ocular surgeries.

The goal of this activity is to evaluate the use of tissue adhesives for ocular surgeries.

Upon completion of this activity, participants will be able to:

Distinguish the most important intervention to improve wound healing after an eye injury or surgery
Compare cyanoacrylate and fibrin glues in ocular surgeries
Evaluate novel tissue adhesives under investigation for use in ocular surgeries
Analyze laser welding and laser soldering in ocular surgeries

Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Author(s)

Heyjin C. Park

Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore

Disclosures

Disclosure: Heyjin C. Park has disclosed no relevant financial relationships.

Ravi Champakalakshmi

Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore

Disclosures

Disclosure: Ravi Champakalakshmi has disclosed no relevant financial relationships.

Pradeep P. Panengad

Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute; Division of Bioengineering, Faculty of Engineering, National University of Singapore, Singapore

Disclosures

Disclosure: Pradeep P. Panengad has disclosed no relevant financial relationships.

Michael Raghunath, MD, PhD

Division of Bioengineering, Faculty of Engineering, National University of Singapore; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Disclosures

Disclosure: Michael Raghunath, MD, PhD, has disclosed no relevant financial relationships.

Jodhbir S. Mehta, FRCS (Ed)

Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute; Singapore National Eye Centre; Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore; Department of Clinical Sciences, Duke-NUS Graduate Medical School, Singapore

Disclosures

Disclosure: Jodhbir S. Mehta, FRCS (Ed), has disclosed no relevant financial relationships.

Editor(s)

Elisa Manzotti

Editorial Director, Future Science Group, London, United Kingdom

Disclosures

Disclosure: Elisa Manzotti has disclosed no relevant financial relationships.

CME Author(s)

Charles P. Vega, MD

Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine

Disclosures

Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.

CME Reviewer(s)

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Sarah Fleischman

CME Program Manager, Medscape, LLC

Disclosures

Disclosure: Sarah Fleischman has disclosed no relevant financial relationships.

Accreditation Statements

For Physicians

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Expert Reviews Ltd. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape Education encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

From Expert Review of Ophthalmology

CME

Tissue Adhesives in Ocular Surgery

Authors: Heyjin C. Park; Ravi Champakalakshmi; Pradeep P. Panengad; Michael Raghunath, MD, PhD; Jodhbir S. Mehta, FRCS (Ed)Faculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 11/21/2011

Valid for credit through: 11/21/2012

processing....

Abstract and Introduction

Abstract

Tissue adhesive sealants have been used as substitutes for sutures in ophthalmic surgery in recent years since the latter may cause irritation, inflammation and infection. Tissue adhesives were developed as suture adjuncts and alternatives for sealing wounded tissues. They are gaining popularity for their ease of use and postoperative comfort. Two broad classes of tissue adhesives, synthetic and biological, have been reported in previous studies. Cyanoacrylate-based synthetic tissue adhesives have been conventionally used for corneal perforation surgeries. Fibrin glue is a bioadhesive developed from blood plasma. Aside from these surface sealants, a new class of compounds termed biodendrimers has also found a use in ophthalmic surgery. Other adhesives in development include acrylic-based adhesives, polyethylene glycol hydrogels, chondroitin sulfate, riboflavin-fibrinogen compounds, photoactivated serum albumin solder and photo-polymerized hyaluronic acid compounds. This article aims to cover the therapeutic uses and application techniques of the aforementioned tissue adhesives in ophthalmology.

Introduction

The application of tissue adhesives in ophthalmology started as early as the 19th century.^[1] The first surgical application of tissue adhesive was described by performing sutureless ocular surgery in rabbits using methyl-2-cyanoacrylate.^[2] Later, from the start of the 20th century, various other tissue adhesives were invented and used in ophthalmology. The drive towards the development of an adhesive comes from the complications associated with suturing. These include postoperative discomfort, prolonged healing time, risk of infection as well as prolongation of surgical time, and scarring.

Properties of ideal tissue adhesives include postoperative comfort, cost—effectiveness, rapid setting time and transparency, high tensile strength by creating a strong bridge between wounded margins, easy application, biodegradable and biocompatible. Currently there are two main classes of tissue adhesives: synthetic (e.g., cyanoacrylate and acrylic-based polymers), and biological (e.g., fibrin glue, biodendrimers and riboflavin—fibrinogen compounds). Newly modified adhesives (e.g., chondroitin sulfate [CS] polymer and laser-activated serum albumin adhesive) have been described more recently in ophthalmology. Each of these adhesives has their own advantages and disadvantages. In this article, we shall discuss the uses and applications of the most commonly used tissue adhesives (i.e., cyanoacrylate and fibrin glue) and the recent developments with regard to newly described bioadhesives.

Page 1 of 11

Cyanoacrylate & Acrylic-based Tissue Adhesives

CME Information

Abstract and Introduction
Cyanoacrylate & Acrylic-based Tissue Adhesives
Clinical Uses
Fibrin Glue
Application Techniques
Safety of Fibrin Glue
Investigatory Adhesives
Tissue Transglutaminase Glue
Expert Commentary
Five-year View
Key Issues

References

References

Disclaimer

The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on www.medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

References

Faculty and Disclosures

Author(s)

Heyjin C. Park

Ravi Champakalakshmi

Pradeep P. Panengad

Michael Raghunath, MD, PhD

Jodhbir S. Mehta, FRCS (Ed)

Editor(s)

Elisa Manzotti

CME Author(s)

Charles P. Vega, MD

CME Reviewer(s)

Nafeez Zawahir, MD

Sarah Fleischman

CME

Tissue Adhesives in Ocular Surgery

Target Audience and Goal Statement

Disclosures

Author(s)

Heyjin C. Park

Ravi Champakalakshmi

Pradeep P. Panengad

Michael Raghunath, MD, PhD

Jodhbir S. Mehta, FRCS (Ed)

Editor(s)

Elisa Manzotti

CME Author(s)

Charles P. Vega, MD

CME Reviewer(s)

Nafeez Zawahir, MD

Sarah Fleischman

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Tissue Adhesives in Ocular Surgery

Abstract and Introduction

Abstract

Introduction

Table of Contents